POSTER SESSION III
Tuesday, March 4, 2008 — 9:30 AM - 12:00 Noon
Convention Center Exhibit Hall A
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
182
Expression of MDM2 Oncoprotein Predicts for Poor Survival in Diffuse Large B-Cell Lymphoma with Wild-Type TP53 Gene
(1290)
KH Young, MB Møller, GWB Colleoni, M Sánchez-Beato, TM Green, T Thorborg, MA Piris, JC Eickhoff, M Twohig, AH Young, TD Oberley, JS Malter, JA Ferry, WC Chan, DD Weisenburger, TC Greiner - University of Wisconsin School of Medicine, Madison, WI; Odense University Hospital, Odense, Denmark; Federal University of São Paulo, São Paulo, Brazil; Spanish National Cancer Center, CNIO, Madrid, Spain; Harvard Medical School, Boston, MI; University of Nebraska Medical Center, Omaha, NE
Outcome Prediction in DLBCL Treated with CHOP-Rituximab. Response to CHOP-R in DLBCL Can Be Predicted Using a Panel of IHQ Markers That Includes Gcet1 and PRDM1/Blimp1
(1217)
S Montes-Moreno, SM Rodriguez-Pinilla, A Froes, Y Castro, A Saez, A Lopez, MC Ruiz-Marcellan, C Montalban, M Canales, P Mazorra, E Conde, M Cruz, M Mollejo, C Grande, MA Piris - Spanish National Cancer Centre, Madrid, Spain; Red de Bancos de Tumores de Andalucia, Granada, Spain; Hospital Vall dHebron, Barcelona, Spain; Hospital Ramon y Cajal, Madrid, Spain; H.U.La Paz, Madrid, Spain; H.U. Marques de Valdecilla, Santander, Spain; Hospital Virgen de la Luz, Toledo, Spain; H.U.12 de Octubre, Madrid, Spain
LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with or without Rituximab
(1221)
Y Natkunam, P Farinha, ED Hsi, CP Hans, R Tibshirani, LH Sehn, JM Connors, D Gratzinger, S Zhao, B Pohlman, A Nagler, R Levy, RD Gascoyne, IS Lossos - Stanford University, Stanford; British Columbia Cancer Agency, Vancouver, Canada; Cleveland Clinic Foundation, Cleveland; Nebraska Medical Center, Omaha; Chaim-Sheba Medical Center, Tel Aviv, Israel; University of Miami, Miami
P53 Expression Combined with Germinal Centre B-Cell Phenotype Improves Risk Stratification in Aggressive Diffuse Large B-Cell Lymphoma Patients Treated with High Dose Combination Chemotherapy Followed by Autologous Stem Cell Transplant
(1207)
A Mansoor, F Sheikh, D Demetrick, MTS Rad, X Jiang, N Bahlis, DA Stewart - University of Calgary / Calgary Laboratory Services and TBCC, Calgary, AB, Canada
BCL-6 Protein Expression, and Not the Germinal Centre Immunophenotype, Predicts Favourable Prognosis in a Series of Primary Nodal Diffuse Large B-Cell Lymphomas: A Single Centre Experience
(1276)
S Uccella, C Placidi, S Marchet, I Proserpio, C Chini, G Pinotti, C Capella - Pathology, Varese, Italy; Ospedale di Circolo, Varese, Italy
Expression of the Germinal Center B Cell-Associated Marker LMO2 Versus BCL2 and BCL6 Translocations in Diffuse Large B-Cell Lymphoma
(1156)
DK Durnick, ME Law, Y Natkunam, R Levy, IS Lossos, ED Remstein, A Dogan - Mayo Clinic, Rochester, MN; Stanford University School of Medicine, Palo Alto, CA
Immunohistochemical Profile of Diffuse Large B-Cell Lymphoma in China
(1197)
T Li, LJ Medeiros, P Lin, H Yin, H Guo, CC Yin - UT MD Anderson Cancer Center, Houston, TX; The First Hospital of Peking University, Beijing, China
Nuclear Translocation of NFATc1 Occurs in a Subset of Diffuse Large B Cell Lymphomas
(1226)
RA Patel, CE Sheehan, A Hayner-Buchan, JS Ross, T Nazeer - Albany Medical College, Albany, NY
Morphological and Gene Expression Profile Based Subtypes of Diffuse Large B-Cell Lymphoma - Clinical Relevance
(1239)
SMH Rizvi, M Calaminici, AJ Norton - Barts and the London NHS Trust, and Queen Mary University of London, London, United Kingdom
Immunophenotyping and Molecular Analysis of Primary Bone Lymphoma
(1126)
S Bhagavathi, W Sanger, MA Micale, K Les, JD Wilson, R Kanhere, K Fu - William Beaumont Hospital, Royal Oak, MI; University of Nebraska Medical Center, Omaha, NE
CD23 Is a Useful Marker in the Differential Diagnosis of Mediastinal (Thymic) Large B-Cell Lymphoma and Hodgkin Lymphoma
(1247)
ME Salama, RM Mariappan, K Inamdar, SL Perkins - University of Utah, Salt Lake City; Harvard University, Boston; Henry Ford Hospital, Detroit
Activation of the mTOR Signaling Pathway in Diffuse Large B-Cell Lymphomas
(1265)
W Tam, A Chadburn, YF Liu, DM Knowles - Weill Cornell Medical College, New York, NY
Nur 77 Is a Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma
(1121)
S Almiski, N Razumilava, M Kurrer, J Frank, E Levi - Harper University Hospital, Wayne State University, Detroit; Cantonal Hospital, Aarau, Aarau, Switzerland; John D. Dingell VAMC, Detroit, MI
TCL-1, MUM-1 and CD23 in the Differential Diagnosis of Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma
(1162)
M Garcia, TJ Dickason, P Lin, LJ Medeiros - M.D. Anderson Cancer Ctr, Houston, TX
Clinicopathologic Features of B-Cell Lymphomas with Concurrent BCL2 and C-MYC Gene Rearrangements
(1191)
OK Kolman, M Snuderl, JA Ferry, EP Hochberg, YB Chen, RP Hasserjian, A Rahemtullah - Massachusetts General Hospital, Boston, MA
Characterization of B-Cell Lymphomas with c-myc Rearrangement in a Background of Complex Cytogenetic Abnormalities
(1249)
AC Seegmiller, A Maleki, KS Wilson, W Chen - UT Southwestern Medical Center at Dallas, Dallas, TX
Tumor-Associated S-Phase Fraction Correlates with the Presence of c-MYC Translocation in Aggressive CD10-Expressing B-Cell Lymphomas and May Predict Their Clinical Course
(1132)
DM Cardona, Y Li, KJ Walsh, BA Gray, JW Lynch, RC Braylan, SZ Al-Quran - University of Florida, Gainesville, FL
Bright CD38 Expression Is an Indicator for 8q24/c-myc Aberrations
(1204)
A Maleki, AC Seegmiller, N Karandikar, W Chen - UT Southwestern Medical Center at Dallas, Dallas, TX
Association of Atypical Burkitt Lymphoma/Leukemia with DNA Hyperdiploidy in Pediatric Patients
(1131)
KE Capocelli, I Gurevich, B Greffe, M Wang, S Pearson, K Swisshelm, N Dirks, X Liang - University of Colorado Health Sciences Center, Denver, CO; The Children's Hospital, Denver, Denver, CO
Sporadic Pediatric and Adult Burkitt Lymphomas Share Similar Phenotypic and Genotypic Features
(1145)
S-S Chuang, W-T Huang, P-P Hsieh, Y-C Jung, H Ye, M-Q Du - Chi-Mei Medical Center & Taipei Medical University, Tainan, Taiwan; Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan; Veterans General Hospital-Kaohsiung, Kaohsiung, Taiwan; Sin-Lau Christian Hospital, Tainan, Taiwan; Cambridge University, Cambridge, United Kingdom
Expression of Junctional Adhesion Molecule-C (JAM-C) in B-Cell Lymphoproliferative Disorder - A Preliminary Flow Cytometric Analysis of 30 Cases
(1198)
X Li, XM Zhang, S Ibrahim, C Liu - New York University, School of Medicine, New York, NY
"Clonality" of Genotypic Lineage Discordant from Histoimmunophenotype in Lymphoproliferative Disorders—Origins and Outcomes
(1267)
LHC Tan, ST Lim, CTH Chuah, M Tao, ESC Koay - Singapore General Hospital; National Cancer Centre and National University of Singapore, Singapore, Singapore
Does a Diffuse Pattern Predict the Survival of Patients with Low-Grade Follicle Center Cell Lymphoma?
(1127)
S Bhagavathi, K Gu, F Loberiza, JM Vose, DD Weisenburger - William Beaumont Hospital, Royal Oak, MI; University of Nebraska Medical Center, Omaha, NE
Ki-67 Proliferation Index Correlates with the Histologic Grade and Overall Survival in Follicular Lymphoma Treated with Rituximab
(1222)
H Naushad, Q Hu, DD Weisenburger, JC Chan, L Smith, M Bast, J Armitage, K Fu - University of Nebraska Medical Center, Omaha, NE; Creighton University Medical Center, Omaha, NE
Prognostic Value of NF-kB Activation Status in Follicular Lymphoma
(1279)
H Vakil, M Raoufi, S Hukku, M Kurrer, V Adsay, A Rishi, E Levi - Harper University Hospital, Wayne State University, Detroit; Henry Ford Hospital, Detroit; Cantonal Hospital Aarau, Aarau, Switzerland; Emory University, Atlanta; John D. Dingell VAMC, Detroit
Intratumoral Plasmacytoid Dendritic Cells and T Cells Associate with Increased Survival in Patients with Follicular Lymphoma
(1130)
R Butsch, S Schaerer, D Korol, E Levi, C Renner, N Probst-Hensch, H Moch, M Kurrer - University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland; John D. Dingell VAMC, Detroit, MI; Wayne State University, Detroit, MI; Cantonal Hospital Aarau, Aarau, Switzerland
Splenic Follicular Lymphomas. A Clinicopathological Study of 33 Cases
(1215)
M Mollejo, MS Rodriguez, S Montes, ED Remstein, P Algara, A Dogan, JC Cigudosa, R Juarez, J Menarguez, MA Piris - Hospital Virgen de la Salud, Toledo, Spain; Spanish National Cancer Research Centre, Madrid, Spain; Mayo Clinic, Rochester, MN
Follicular Lymphomas of the Spleen: Multiparameter Analysis of 16 Cases
(1176)
MT Howard, SD Dufresne, SH Swerdlow, JR Cook - Cleveland Clinic, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA
Relationship between Genetic Abnormalities (BCL2 and BCL6 Translocations) and Phenotype in Follicular Lymphoma
(1236)
D Remstein, ME Law, A Dogan, PJ Kurtin, A Feldman - Mayo Clinic, Rochester, MN
button next to any title to add to Itinerary Planner...
Add
